Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome
Manuela Colucci, Andrea Angeletti, Federica Zotta, Rita Carsetti, Francesca Lugani, Lucilla Ravà, Pietro Ravani, Francesco Emma, Gian Marco Ghiggeri, Marina Vivarelli
Topics & Concepts
MedicineCD20RituximabHazard ratioImmunosuppressionInternal medicineImmunologyInterquartile rangePrednisoneOfatumumabGastroenterologyConfidence intervalAntibodyRenal Diseases and GlomerulopathiesPlatelet Disorders and TreatmentsAutoimmune Bullous Skin Diseases